[Form 4] CapsoVision, Inc Insider Trading Activity

Rhea-AI Filing Summary

CapsoVision insider report: Julia S. Gouw, a director of CapsoVision, Inc. (CV), was granted 2,887 Restricted Stock Units (RSUs) on 09/15/2025. Each RSU represents the contingent right to receive one share of the issuer's common stock, and the RSUs are scheduled to vest on December 31, 2025. Following the reported transaction the filing shows 2,887 shares beneficially owned directly attributable to these RSUs. The RSUs have an indicated price of $0 in the filing, and the Form 4 was signed by an attorney-in-fact on behalf of Ms. Gouw on 09/17/2025. No other transactions or derivative securities are reported in this filing.

Positive

• 2,887 RSUs granted to a director aligns the director's interests with shareholders through equity ownership
• Clear vesting date: RSUs scheduled to vest on December 31, 2025, providing transparency on timing of share issuance

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Director received time‑based RSUs that align her economic incentives with shareholders, vesting at year-end.

The grant of 2,887 RSUs to a director is a routine equity‑based compensation mechanism that ties the director's interests to stock performance through a defined vesting date of December 31, 2025. The Form 4 discloses a direct beneficial ownership of 2,887 shares following the grant. Because the filing shows a single non‑derivative award and no disposals or exercises, the event appears administrative and typical for board compensation. Materiality is likely low absent additional context on company size or outstanding share count, which are not provided in this filing.

Compensation Analyst

TL;DR: A modest RSU award was recorded; vesting schedule is explicit but financial impact is not quantifiable from this form alone.

The Form 4 reports 2,887 RSUs granted on 09/15/2025 that vest on 12/31/2025, each converting to one share of common stock. The filing lists a $0 price, consistent with standard RSU awards that convert to shares rather than requiring purchase. The document does not state grant date fair value, total outstanding shares, or how this award compares to prior grants, so compensation expense and dilution impact cannot be determined from the filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

GOUW JULIA S

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CA 95070

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit (RSU)	(1)	09/15/2025		A		2,887		(2)	(2)	Common Stock	2,887	$0	2,887	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. These RSUs are scheduled to vest on December 31, 2025

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Julia S. Gouw	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CapsoVision (CV) report in this Form 4 for Julia S. Gouw?

The Form 4 reports a grant of 2,887 Restricted Stock Units (RSUs) to Julia S. Gouw on 09/15/2025, with vesting on 12/31/2025.

How many shares will Julia S. Gouw own after the reported transaction?

The filing shows 2,887 shares beneficially owned directly following the reported transaction.

When do the RSUs granted to the director vest?

The RSUs are scheduled to vest on December 31, 2025.

Did the Form 4 report any sales, exercises, or disposals by Julia S. Gouw?

No. The Form 4 lists only an acquisition of RSUs; there are no sales, exercises, or disposals reported.

Was a purchase price reported for the RSUs on the Form 4?

The filing shows a price of $0, consistent with RSUs that convert to shares without a cash purchase.